文献速递精神分裂症与精神病性障碍会诊联络精神医学

多组学分析揭示瘦素/PPAR基因集罕见变异与ABCG1高甲基化对抗精神病药所致代谢综合征的作用

Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes.
PubMed 文献 · Mol Psychiatry · 2022-09-05

该研究对伴或不伴抗精神病药所致代谢综合征(APs-induced Mets)的精神分裂症患者进行全基因组、全外显子组和表观基因组关联分析,发现瘦素和PPAR基因集罕见功能变异失衡及ABCG1高甲基化与Mets相关,并在线虫和HepG2细胞中验证了候选基因功能,其中PTPN11过表达导致胰岛素抵抗。

要点

  • 瘦素/PPAR基因集罕见功能变异在APs-induced Mets与Non-Mets队列间分布失衡。
  • ABCG1特定区域高甲基化与APs-induced Mets相关,且与HepG2细胞中TC和TG水平升高相关。
  • 线虫中17个基因被验证与奥氮平诱导的脂肪沉积相关,PTPN11过表达导致糖反应受损和胰岛素抵抗。

核心结论

  • 瘦素/PPAR基因集罕见功能变异和ABCG1高甲基化可能参与抗精神病药所致代谢综合征的发生机制。
  • PTPN11过表达导致胰岛素抵抗,药理学抑制PTPN11可保护HepG2细胞免受APs诱导的胰岛素抵抗。

研究设计与样本

  • 研究对伴或不伴APs-induced Mets的精神分裂症患者进行全基因组、全外显子组测序(WES)和表观基因组关联研究,并进行体外和体内功能验证。
  • 在秀丽隐杆线虫中筛选组学候选基因,并在HepG2细胞中进行功能验证。

主要发现

  • 瘦素和过氧化物酶体增殖物激活受体(PPARs)基因集的罕见功能变异在APs-induced Mets与Non-Mets队列间失衡。
  • APs-induced Mets患者ABCG1(chr21:43642166-43642366)存在高甲基化(校正P < 0.05),该区域高甲基化与HepG2细胞中较高TC和TG水平相关。
  • 线虫中17个基因被验证与奥氮平(OLA)诱导的脂肪沉积相关,其中若干基因在Mets队列及APs诱导的体外/体内模型中表达差异。
  • PTPN11过表达表现出糖反应受损和胰岛素抵抗,药理学抑制PTPN11可保护HepG2细胞免受APs诱导的胰岛素抵抗。

临床怎么用

  • 对于使用抗精神病药的精神分裂症患者,可关注瘦素/PPAR通路罕见变异及ABCG1甲基化状态作为代谢综合征风险标志的潜在价值。
  • PTPN11可能作为减轻抗精神病药所致胰岛素抵抗的潜在药理学靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antipsychotic-induced metabolic syndrome (APs-induced Mets) is the most common adverse drug reaction, which affects more than 60% of the psychiatric patients. Although the etiology of APs-induced Mets has been extensively investigated, there is a lack of integrated analysis of the genetic and epigenetic factors. In this study, we performed genome-wide, whole-exome sequencing (WES) and epigenome-wide association studies in schizophrenia (SCZ) patients with or without APs-induced Mets to find the underlying mechanisms, followed by in vitro and in vivo functional validations. By population-based omics analysis, we revealed that rare functional variants across in the leptin and peroxisome proliferator-activated receptors (PPARs) gene sets were imbalanced with rare functional variants across the APs-induced Mets and Non-Mets cohort. Besides, we discovered that APs-induced Mets are hypermethylated in ABCG1 (chr21:43642166-43642366, adjusted P < 0.05) than Non-Mets, and hypermethylation of this area was associated with higher TC (total cholesterol) and TG (triglycerides) levels in HepG2 cells. Candidate genes from omics studies were furtherly screened in C. elegans and 17 gene have been verified to associated with olanzapine (OLA) induced fat deposit. Among them, several genes were expressed differentially in Mets cohort and APs-induced in vitro/in vivo models compared to controls, demonstrating the validity of omics study. Overexpression one of the most significant gene, PTPN11, exhibited compromised glucose responses and insulin resistance. Pharmacologic inhibition of PTPN11 protected HepG2 cell from APs-induced insulin resistance. These findings provide important insights into our understanding of the mechanism of the APs-induced Mets.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhou W, Sun J, Huai C, et al. Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes. Mol Psychiatry. 2022. PMID: 36065016. doi:10.1038/s41380-022-01759-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。